Vanda submits FDA application for rare skin disorder drug
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/25/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
| (NASDAQ: ANAB) | Delayed: 48.73 +0.63 (1.31%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $48.10 | 52 Week High | $ | |||
| Open | $48.19 | 52 Week Low | $ | |||
| Day High | $48.89 | P/E | N/A | |||
| Day Low | $47.05 | EPS | $ | |||
| Volume | 468,215 | |||||
| Vanda Pharmaceuticals, Inc. (NASDAQ: VNDA) | Delayed: 4.01 -0.04 (0.99%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.05 | 52 Week High | $18.00 | |||
| Open | $4.04 | 52 Week Low | $6.91 | |||
| Day High | $4.07 | P/E | N/A | |||
| Day Low | $3.88 | EPS | $-0.67 | |||
| Volume | 830,813 | |||||
